真實 Q3 --12-31 0001388295 十年 P5Y P5Y P5Y 0001388295 2024-01-01 2024-09-30 0001388295 2024-09-30 0001388295 2023-12-31 0001388295 us-gaap:非關聯方成員 2024-09-30 0001388295 us-gaap:非關聯方成員 2023-12-31 0001388295 us-gaap:關聯方會員 2024-09-30 0001388295 us-gaap:關聯方會員 2023-12-31 0001388295 us-gaap: A優先股成員 2024-09-30 0001388295 us-gaap: A優先股成員 2023-12-31 0001388295 ONEI : 系列B可轉換優先股票會員 2024-09-30 0001388295 ONEI : 系列B可轉換優先股票會員 2023-12-31 0001388295 2024-07-01 2024-09-30 0001388295 2023-07-01 2023-09-30 0001388295 2023-01-01 2023-09-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-12-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股成員 2023-12-31 0001388295 us-gaap:普通股成員 2023-12-31 0001388295 us-gaap:額外實收資本成員 2023-12-31 0001388295 us-gaap:留存收益成員 2023-12-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-03-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股成員 2024-03-31 0001388295 us-gaap:普通股成員 2024-03-31 0001388295 us-gaap:額外實收資本成員 2024-03-31 0001388295 us-gaap:留存收益成員 2024-03-31 0001388295 2024-03-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-06-30 0001388295 us-gaap: 優先股成員 ONEI:B系列可轉換優先股成員 2024-06-30 0001388295 us-gaap:普通股成員 2024-06-30 0001388295 us-gaap:額外實收資本成員 2024-06-30 0001388295 us-gaap:留存收益成員 2024-06-30 0001388295 2024-06-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2022-12-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉債優先股成員 2022-12-31 0001388295 us-gaap:普通股成員 2022-12-31 0001388295 us-gaap:額外實收資本成員 2022-12-31 0001388295 us-gaap:留存收益成員 2022-12-31 0001388295 2022-12-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-03-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股成員 2023-03-31 0001388295 us-gaap:普通股成員 2023-03-31 0001388295 us-gaap:額外實收資本成員 2023-03-31 0001388295 us-gaap:留存收益成員 2023-03-31 0001388295 2023-03-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-06-30 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股會員 2023-06-30 0001388295 us-gaap:普通股成員 2023-06-30 0001388295 us-gaap:額外實收資本成員 2023-06-30 0001388295 us-gaap:留存收益成員 2023-06-30 0001388295 2023-06-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-01-01 2024-03-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股會員 2024-01-01 2024-03-31 0001388295 us-gaap:普通股成員 2024-01-01 2024-03-31 0001388295 us-gaap:額外實收資本成員 2024-01-01 2024-03-31 0001388295 us-gaap:留存收益成員 2024-01-01 2024-03-31 0001388295 2024-01-01 2024-03-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-04-01 2024-06-30 0001388295 us-gaap: 優先股成員 ONEI:B系列可轉換優先股會員 2024-04-01 2024-06-30 0001388295 us-gaap:普通股成員 2024-04-01 2024-06-30 0001388295 us-gaap:額外實收資本成員 2024-04-01 2024-06-30 0001388295 us-gaap:留存收益成員 2024-04-01 2024-06-30 0001388295 2024-04-01 2024-06-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-07-01 2024-09-30 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股票成員 2024-07-01 2024-09-30 0001388295 us-gaap:普通股成員 2024-07-01 2024-09-30 0001388295 us-gaap:額外實收資本成員 2024-07-01 2024-09-30 0001388295 us-gaap:留存收益成員 2024-07-01 2024-09-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-01-01 2023-03-31 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股票成員 2023-01-01 2023-03-31 0001388295 us-gaap:普通股成員 2023-01-01 2023-03-31 0001388295 us-gaap:額外實收資本成員 2023-01-01 2023-03-31 0001388295 us-gaap:留存收益成員 2023-01-01 2023-03-31 0001388295 2023-01-01 2023-03-31 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-04-01 2023-06-30 0001388295 us-gaap: 優先股成員 ONEI : B系列可轉換優先股成員 2023-04-01 2023-06-30 0001388295 us-gaap:普通股成員 2023-04-01 2023-06-30 0001388295 us-gaap:額外實收資本成員 2023-04-01 2023-06-30 0001388295 us-gaap:留存收益成員 2023-04-01 2023-06-30 0001388295 2023-04-01 2023-06-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-07-01 2023-09-30 0001388295 us-gaap: 優先股成員 ONEI:B系列可轉換優先股成員 2023-07-01 2023-09-30 0001388295 us-gaap:普通股成員 2023-07-01 2023-09-30 0001388295 us-gaap:額外實收資本成員 2023-07-01 2023-09-30 0001388295 us-gaap:留存收益成員 2023-07-01 2023-09-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2024-09-30 0001388295 us-gaap: 優先股成員 ONEI : B系列一號可轉換優先股會員 2024-09-30 0001388295 us-gaap:普通股成員 2024-09-30 0001388295 us-gaap:額外實收資本成員 2024-09-30 0001388295 us-gaap:留存收益成員 2024-09-30 0001388295 us-gaap: 優先股成員 us-gaap: A優先股成員 2023-09-30 0001388295 us-gaap: 優先股成員 ONEI:B系列可轉換優先股會員 2023-09-30 0001388295 us-gaap:普通股成員 2023-09-30 0001388295 us-gaap:額外實收資本成員 2023-09-30 0001388295 us-gaap:留存收益成員 2023-09-30 0001388295 2023-09-30 0001388295 us-gaap:建築改善成員 2024-09-30 0001388295 ONEI : 訂閱和許可會員 2024-07-01 2024-09-30 0001388295 ONEI : 訂閱和許可會員 2023-07-01 2023-09-30 0001388295 ONEI : 訂閱和許可會員 2024-01-01 2024-09-30 0001388295 ONEI : 訂閱和許可會員 2023-01-01 2023-09-30 0001388295 ONEI : 培訓和教育會員 2024-07-01 2024-09-30 0001388295 ONEI : 培訓和教育會員 2023-07-01 2023-09-30 0001388295 ONEI : 培訓和教育會員 2024-01-01 2024-09-30 0001388295 ONEI : 培訓和教育會員 2023-01-01 2023-09-30 0001388295 srt : 之前期間重新分類調整的修訂成員 2023-06-30 0001388295 srt : 之前報告的場景成員 2023-06-30 0001388295 srt : 之前報告的場景成員 2023-09-30 0001388295 srt : 之前期間重新分類調整的修訂成員 2023-09-30 0001388295 srt : 之前報告的場景成員 2023-01-01 2023-06-30 0001388295 srt : 之前期間重新分類調整的修訂成員 2023-01-01 2023-06-30 0001388295 2023-01-01 2023-06-30 0001388295 srt : 之前報告的場景成員 2023-01-01 2023-09-30 0001388295 srt : 之前期間重新分類調整的修訂成員 2023-01-01 2023-09-30 0001388295 ONEI : 羅蘭·戴 會員 2024-01-01 2024-09-30 0001388295 ONEI : 羅蘭·戴 會員 2024-09-30 0001388295 ONEI : 羅蘭·戴 會員 2023-01-01 2023-09-30 0001388295 ONEI : 羅蘭·戴 會員 2023-12-31 0001388295 ONEI : 索爾·利爾 會員 2024-01-01 2024-09-30 0001388295 ONEI : 索爾·利爾 會員 2024-09-30 0001388295 ONEI : 羅蘭·戴 會員 us-gaap: 可轉換債務成員 2024-01-01 2024-09-30 0001388295 ONEI : 羅蘭·戴會員 ONEI : B系列可轉換優先股票會員 2024-09-30 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保票據支付會員 2024-05-10 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保票據支付會員 2024-05-10 2024-05-10 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保票據支付會員 2024-06-12 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級有擔保票據應付款會員 2024-06-12 2024-06-12 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級有擔保票據應付款會員 2024-08-12 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級有擔保票據應付款會員 2024-08-12 2024-08-12 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級有擔保票據應付款會員 2024-08-27 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保 promissory notes 應付會員 2024-08-27 2024-08-27 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保 promissory notes 應付會員 2024-09-26 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保 promissory notes 應付會員 2024-09-26 2024-09-26 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保 promissory notes 應付會員 2024-09-30 0001388295 ONEI : 羅蘭·戴會員 ONEI : senior secured promissory notes payable 會員 2023-12-31 0001388295 ONEI : 羅蘭·戴會員 2023-01-01 2023-12-31 0001388295 ONEI : B系列一號可轉換優先股會員 2023-05-01 0001388295 2024-02-06 2024-02-06 0001388295 2024-02-06 0001388295 us-gaap: A優先股成員 2008-04-30 0001388295 us-gaap: A優先股成員 2023-05-01 0001388295 us-gaap: A優先股成員 2023-05-01 2023-05-01 0001388295 ONEI : A系列一號優先股會員 2024-09-30 0001388295 ONEI : A系列一類優先股會員 2023-12-31 0001388295 ONEI : B系列一類可轉換優先股會員 2015-10-31 0001388295 ONEI : B系列一類可轉換優先股會員 2015-10-01 2015-10-31 0001388295 ONEI : B系列一類可轉換優先股會員 ONEI : 元語言會員 2023-05-02 0001388295 ONEI : B系列二類可轉換優先股會員 2015-10-31 0001388295 ONEI : B系列二類可轉換優先股會員 2015-10-01 2015-10-31 0001388295 ONEI : B系列二類可轉換優先股會員 2024-09-30 0001388295 ONEI:系列B兩可轉換優先股票會員 2023-12-31 0001388295 us-gaap:Warrants成員 2024-09-30 0001388295 us-gaap:員工股票期權成員 srt : 董事 會員 2024-01-24 2024-01-24 0001388295 us-gaap:員工股票期權成員 srt : 董事 會員 2024-01-24 0001388295 us-gaap:員工股票期權成員 美國通用會計準則: 員工股票成員 2024-08-05 2024-08-05 0001388295 us-gaap:員工股票期權成員 美國通用會計準則: 員工股票成員 2024-08-05 0001388295 us-gaap:員工股票期權成員 srt : 董事 會員 美國通用會計準則: 員工股票成員 2024-08-05 2024-08-05 0001388295 us-gaap:員工股票期權成員 美國通用會計準則: 員工股票成員 2024-08-19 2024-08-19 0001388295 us-gaap:員工股票期權成員 美國通用會計準則: 員工股票成員 2024-08-19 0001388295 us-gaap:員工股票期權成員 2024-01-01 2024-09-30 0001388295 us-gaap:員工股票期權成員 2024-09-30 0001388295 us-gaap:Warrants成員 2023-12-31 0001388295 us-gaap:Warrants成員 2024-01-01 2024-09-30 0001388295 us-gaap:員工股票期權成員 2023-12-31 0001388295 ONEI : OEM協議成員 us-gaap:後續事件成員 2024-10-08 2024-10-08 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保票據應付會員 us-gaap:後續事件成員 2024-10-14 0001388295 ONEI : 羅蘭·戴會員 ONEI : 高級擔保票據應付會員 us-gaap:後續事件成員 2024-10-14 2024-10-14 0001388295 us-gaap:員工股票期權成員 美國通用會計準則: 員工股票成員 us-gaap:後續事件成員 2024-10-29 2024-10-29 iso4217:美元指數 xbrli:股份 iso4217:美元指數 xbrli:股份 xbrli:純

 

 

 

美國

證券 交易委員會

華盛頓, D.C. 20549

 

表格 10-Q/A

(修正案第1號)

 

季度 報告根據1934年證券交易法第13或15(d)節

 

截至 季度期間 9月30日 2024

 

 

過渡 根據1934年證券交易法第13條或15條(d)報告

 

過渡期從______到______。

 

委員會 文件編號 000-56565

 

ONEMETA INC.

(註冊人按其章程規定的準確名稱)

 

內華達   20-5150818

(州或其他管轄區的

公司註冊或組織)

 

(IRS僱主)

識別號)

 

450 南400東, 200套房, 豐饒, 猶他 84010

(主要執行辦公室地址,包括郵政編碼)

註冊人的 電話號碼,包括區號: (702) 550-0122

 

根據該法第12(b)條註冊的證券:

 

每類的標題   交易所 標的   註冊的交易所名稱
無。        

 

請通過勾選標記表示註冊人(1)在前12個月內是否提交了根據1934年證券交易法第13或15(d)條規定要求提交的所有報告(或在註冊人要求提交此類報告的較短期間內),以及(2)在過去90天內是否受到提交要求。 ☒ 否 ☐

 

請打勾指明註冊人是否在過去12個月(或註冊人被要求提交此類文件的較短時間內)根據S-T規則405,電子提交了所有必須提交的互動數據文件。 ☒ 否 ☐

 

根據證券交易所法案規則12B-2的定義,在勾選標誌處指出發行人是屬於大型加速文件申報人、加速文件申報人、非加速文件申報人、小型報告公司還是新興成長公司

 

大型 加速披露方 ☐

加速 報告人

非加速 報告人 小型 報告公司 新興 成長型公司

 

如果是新興成長公司,請勾選,如果註冊人已選擇不使用根據交易所法案第13(a)條提供的任何新的或修改的財務會計準則的延長過渡期,請勾選。

 

請勾選適用的圓圈,表示註冊登記者是否是空殼公司(根據交易所法案第12b-2條的定義)。是 ☐ 否

 

說明截至最近可行日期,各註冊人的普通股類別的流通股數量。

 

標題 或類別   截至2024年9月30日 已發行股份
普通 股票,$0.001 面值   33,964,960
     
系列 A 優先股,面值$0.001   2,068
     
系列 b-1 可轉換優先股,面值$0.001   8,619,420

 

 

 

 

 

 

說明性通知

 

本修正案1號至10-Q表格(本「修正案」或「修正案1號」)修正了截至2024年9月30日的季度報告,該報告最初於2024年11月13日由內華達州的OneMeta, Inc.(「ONEI」,「公司」,「我們」或「我們的」)提交(「原始文件」)。我們提交本修正案以重新說明截至2023年6月30日和2023年9月30日的基本報表(統稱爲「以前的基本報表」)。以前的基本報表已被重新說明,以糾正2023年5月2日進行的先前年度軟體收購所發出的額外股份的估值。

 

此錯誤的影響僅限於公司的 運營結果、每股損失,且該錯誤未影響公司的營業收入或淨資產。該錯誤未導致 公司的業務計劃或事件控制項發生任何變化,也不影響任何監管要求或管理薪酬。

 

本修正案未反映我們原始文件提交後發生的事件,也未修改或更新這些披露內容,除非在我們的財務報表腳註後續事件披露中說明。我們原始文件的以下部分已經被修正:

 

● 第一部分 – 項目1 - 我們原始文件的財務信息已被修正;以及

● 第二部分 - 項目4 - 控制和程序

 

本修正案已於當前日期簽署,且我們首席執行官和財務長的所有認證均爲當前日期。因此,本修正案應與我們在提交原始文件後向證券交易委員會提交的文件一起閱讀。

 

 

 

 

目錄

 

部分 I. 財務信息 3
     
項目 1. 基本報表(未經審計) 3
     
  資產負債表 3
     
  運營報表 4
     
  股東權益(赤字)變動表 5
     
  現金流量表 6
     
  基本報表附註(未經審計) 7
     
項目 2. 管理層對控制項和經營結果的討論與分析 17
     
條目 4. 控制和程序 23
     
部分 II. 其他信息 24
     
項目 1. 法律訴訟 24
     
項目 1A. Risk Factors 24
     
第6項。 展覽品 25
     
簽名 26

 

2

 

 

第一部分 - 財務信息

 

項目 1. 基本報表

ONEMETA INC.

資產負債表 資產負債表

(未經審計)

 

   9月30日
2024
   12月31日,
2023
 
         
資產          
流動資產:          
現金  $24,254   $1,129,935 
應收賬款   6,160    6,935 
預付賬款及其他流動資產   16,192    6,820 
總流動資產   46,606    1,143,690 
           
總資產  $46,606   $1,143,690 
           
負債和股東權益(赤字)          
流動負債:          
應付賬款  $583,152   $522,917 
應付費用   23,031    - 
應計費用,關聯方   471,658    281,012 
遞延收入   16,000    - 
應付票據,關聯方   221,990    221,990 
高級擔保票據應付,關聯方   549,000    - 
總流動負債   1,864,831    1,025,919 
總負債   1,864,831    1,025,919 
           
承諾與或有事項   -    - 
           
股東權益(赤字)          
優先股,$0.001 面值, 50,000,000 授權的股份,          
A系列優先股,$0.001 面值, 2,068 授權股份, 2,068
已發行和流通
   2    2 
B-1系列可轉換優先股,$0.001 面值, 8,619,420 授權股份, 8,619,420 已發行並在外流通的股份   862    862 
普通股,$0.001 面值, 500,000,000 已授權的股份,
33,964,96032,995,460 發行的股份和流通的股份,分別爲
   33,965    32,996 
額外實收資本   34,998,705    33,992,707 
累計虧損   (36,851,759)   (33,908,796)
股東權益(赤字)總額   (1,818,225)   117,771 
總負債和股東權益(赤字)  $46,606   $1,143,690 

 

請參見附帶的未經審計的基本報表的說明。

 

3

 

 

ONEMETA INC.

經營 報表

(未經審計)

 

   截至三個月   截至三個月   截至九個月   截至九個月 
   2024年9月30日   2023年9月30日   2024年9月30日   九月三十日
2023
 
               經重述 
營業收入  $3,478   $9,162   $14,354   $57,124 
總營業收入   3,478    9,162    14,354    57,124 
                     
營業費用:                    
研究和開發   202,168    203,588    653,732    540,092 
一般管理費用   537,164    515,146    1,672,388    3,455,292 
廣告與營銷   25,336    71,253    78,809    161,038 
法律和專業費用   139,600    265,893    491,733    387,809 
                     
總營業費用   904,268    1,055,880    2,896,662    4,544,231 
                     
運營損失   (900,790)   (1,046,718)   (2,882,308)   (4,487,107)
                     
其他支出:                    
                     
利息支出   (34,563)   (10,990)   (60,655)   (31,462)
                     
其他費用總計   (34,563)   (10,990)   (60,655)   (31,462)
                     
淨損失  $(935,353)  $(1,057,708)  $(2,942,963)  $(4,518,569)
                     
每股普通股淨損失:                    
基本  $(0.03)  $(0.03)  $(0.09)  $(0.16)
稀釋  $(0.03)  $(0.03)  $(0.09)  $(0.16)
                     
加權平均普通股流通股數:                    
基本   33,721,004    30,224,461    33,312,494    27,820,812 
稀釋   33,721,004    30,224,461    33,312,494    27,820,812 

 

請參見附帶的未經審計的基本報表的說明。

 

4

 

 

ONEMETA INC.

股東權益(赤字)變動表

截至2024年和2023年9月30日的九個月

(未經審計)

 

   股份   金額     股份   金額   股份   金額   股份   金額   資本   赤字   總計 
   B-1系列可轉換優先股     A系列優先股   B-1系列可轉換優先股   普通股  

額外

已支付的

   累計     
   股份   金額     股份   金額   股份   金額   股份   金額   資本   赤字   總計 
                                               
截至2023年12月31日的餘額   -   $-      2,068   $2    8,619,420   $862    32,995,460   $32,996   $33,992,707   $(33,908,796)  $117,771 
以現金髮行的普通股   -    -      -    -    -    -    87,500    87    34,913    -    35,000 
基於股票的補償   -    -      -    -    -    -    -    -    84,663    -    84,663 
實繳資本   -    -      -    -    -    -    -    -    4,448    -    4,448 
隱含利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (937,097)   (937,097)
餘額,2024年3月31日   -    -      2,068    2    8,619,420    862    33,082,960    33,083    34,118,396    (34,845,893)   (693,550)
以現金髮行的普通股   -    -      -    -    -    -    582,000    582    465,018    -    465,600 
基於股票的補償   -    -      -    -    -    -    -    -    92,338    -    92,338 
隱含利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (1,070,513)   (1,070,513)
餘額,2024年6月30日   -    -      2,068    2    8,619,420    862    33,664,960    33,665    34,677,417    (35,916,406)   (1,204,460)
以現金髮行的普通股   -    -      -    -    -    -    300,000    300    224,700    -    225,000 
基於股票的補償   -    -      -    -    -    -    -    -    94,923    -    94,923 
推算利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (935,353)   (935,353)
餘額,2024年9月30日   -   $-      2,068   $2    8,619,420   $862    33,964,960   $33,965   $34,998,705   $(36,851,759)  $(1,818,225)
                                                          
截至2022年12月31日的餘額   5,673,346   $4,016,616      2,068   $2    -   $-    24,983,593   $24,984   $24,156,001   $(27,761,733)   (3,580,746)
以現金髮行的普通股   -    -      -    -    -    -    437,500    437    174,563    -    175,000 
基於股票的補償   -    -      -    -    -    -    30,000    30    11,970    -    12,000 
隱含利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (542,413)   (542,413)
餘額,2023年3月31日   5,673,346    4,016,616      2,068    2    -    -    25,451,093    25,451    24,344,199    (28,304,146)   (3,934,494)
以現金髮行的普通股   -    -      -    -    -    -    2,936,667    2,937    1,005,063    -    1,008,000 
爲前一年發行的額外股份
軟體收購
   2,946,074    2,085,762      -    -    -    -    1,772,800    1,773    131,187    -    132,960 
基於股票的補償   -    -      -    -    -    -    -    -    79,666    -    79,666 
隱含利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (2,918,448)   (2,918,448)
餘額,2023年6月30日 - 經調整   8,619,420    6,102,378      2,068    2    -    -    30,160,560    30,161    25,561,780    (31,222,594)   (5,630,651)
以現金髮行的普通股   -    -      -    

-
    

-
        437,500    437    174,563    -    175,000 
基於股票的補償   -    -      -    -    -    -    50,000    50    54,146    -    54,196 
中間權益的重新分類   (8,619,420)   (6,102,378)     -    -    8,619,420    862    -    -    6,101,516    -    6,102,378 
隱含利息   -    -      -    -    -    -    -    -    1,665    -    1,665 
淨損失   -    -      -    -    -    -    -    -    -    (1,057,708)   (1,057,708)
截至2023年9月30日的餘額 – 經重述   -   $-      2,068   $2    8,619,420   $862    30,648,060   $30,648   $31,893,670   $(32,280,302)  $(355,120)

 

請參見附帶的未經審計的基本報表的說明。

 

5

 

 

ONEMETA INC.

現金流量表

截至2024年和2023年9月30日的九個月

(未經審計)

 

   2024年9月30日   2023年9月30日 
   經重述 
經營活動產生的現金流量          
淨損失  $(2,942,963)  $(4,518,569)
調整以調和淨虧損與經營活動中使用的現金:          
隱含利息   4,995    4,995 
爲前一年軟體收購而發行的額外股份   -    2,218,722 
基於股票的補償   271,924    145,862 
攤銷   -    293,857 
淨變化在:          
應收賬款   775    (12,135)
預付賬款及其他流動資產   (9,372)   - 
應付賬款   318,210    447,693 
應付費用   23,031    - 
應計費用,關聯方   (62,881)   (125,883)
遞延收入   16,000    - 
           
經營活動中使用的現金流   (2,380,281)   (1,545,458)
           
融資活動的現金流量:          
來自高級有擔保票據應付賬款的收入,關聯方   549,000    - 
普通股發行所得   725,600    1,358,000 
來自預付款的收入,關聯方   72,000    - 
預付款的償還,關聯方   (72,000)   - 
           
融資活動提供的現金流   1,274,600    1,358,000 
           
現金淨變動   (1,105,681)   (187,458)
現金,期初餘額   1,129,935    400,703 
現金,期末餘額  $24,254   $213,245 
           
補充現金流信息          
           
支付的利息費用  $-   $- 
支付的所得稅現金  $-   $- 
           
非現金交易          
代表公司支付的費用  $257,975   $352,952 
實繳資本  $4,448   $- 
夾層股權的重新分類  $-   $6,102,378 

 

請參見附帶的未經審計的基本報表的說明。

 

6

 

 

OneMeta 公司

(前稱 OneMeta 人工智能)

基本報表備註

(未經審計)

 

注意 1. 財務報表的基礎

 

本 附帶的未經審計的中期基本報表由OneMeta Inc.(「我們」、「我們的」、「OneMeta」或「公司」)編制,符合美國的一般公認會計原則以及證券交易委員會(「SEC」)的規則,應與公司2023財年的基本報表及其附註共同閱讀。管理層認爲,所有調整,包括常規重複調整,已在此反映,以公正地呈現財務狀況和中期運營結果。我們的中期運營結果不一定代表全年預期的結果。由於與2023財年基本報表中的披露內容基本重複,相關基本報表的附註已被省略。

 

OneMeta 最初於2006年7月3日在內華達州註冊爲Promotions on Wheels Holdings, Inc.。在2008年12月26日,公司名稱更改爲Blindspot Alert, Inc.。在2009年9月11日,公司名稱更改爲WebSafety, Inc. 在2021年3月23日,公司名稱更改爲VeriDetx CORP。 在2021年6月8日,公司名稱更改爲WebSafety, Inc. 在2022年7月10日,公司名稱更改爲OneMeta 人工智能。 在2023年6月20日,公司名稱更改爲OneMeta Inc.

 

註釋 2. 重要會計政策概述

 

估算的使用

 

在準備符合美國通常接受的會計原則的基本報表時,管理層需要進行估計和假設,這些估計和假設會影響基本報表及其附註中報告的金額。實際結果可能與附帶的基本報表中涉及普通股和股票基礎補償的估計不同。

 

現金 及現金等價物

 

現金等價物包括所有原始到期日在三個月或更短時間內的高度流動性投資。

 

應收賬款

 

應收賬款包括來自客戶的無擔保款項。公司按應收賬款的面值減去信用損失準備金額來記錄其應收賬款。信用損失準備是基於管理層對每年可能損失的估計,基於過往經驗以及對客戶檔案和應收賬款餘額的老化情況的審查。截至2024年9月30日和2023年12月31日,存在 信用損失準備。

 

資產 和設備

 

固定資產 以成本計價。增加的部分會資本化,而日常維護和修理費用會在發生時計入費用。折舊 採用直線法計算,按照資產的預計使用壽命進行如下處理:

 

   預計
類別  使用壽命
建築及改善  3

 

7

 

 

關聯方

 

公司遵循ASC 850,「相關方披露」,用於識別相關方和披露相關方交易。

 

金融工具的公允價值

 

公司的金融工具主要由現金和應付賬款組成。這些金融工具的賬面價值與其公允價值接近,因爲它們是短期性質,或利率接近市場利率。

 

營業收入 確認

 

本公司依據ASC主題606《客戶合同的收入》確認營業收入,該主題於2018年1月1日採用修改後的追溯法進行採納,對本公司的比較基本報表沒有影響。營業收入在承諾的商品或服務控制權轉移給客戶時確認,確認的金額反映了本公司預期應獲得的對價,以交換轉移這些商品或服務爲基礎。營業收入是基於以下五步模型確認的:

 

識別 客戶合同
識別 合同中的履約義務
確定 交易價格
將 交易價格分配給合同中的履約義務
當公司滿足績效義務時,確認營業收入

 

我們 達成的營業收入安排中,客戶可以購買訂閱、諮詢服務、培訓和教育的組合。 完全託管的訂閱服務(「Saas-雲計算」)允許客戶在合同期限內訪問託管的軟體,而不需要 佔有軟體。

 

我們 在合同服務期內,按比例確認來自基於承諾交易數量的託管服務的營業收入。服務的交付和消費在時間上均勻地進行,從與承諾交易相關的服務首次提供給客戶之日起,直到合同服務期結束。 超額使用費和基於實際交易數量的費用根據合同條款開具賬單,按照費用產生的時點計入,並作爲變量包含在交易價格中。基於每分鐘或每字的收入,開票與履行模式、客戶利益和消費保持一致,通常適用「按開票」實用處理。按期收費的訂閱收入在合同期內按比例確認,因爲客戶同時獲得並消費基礎服務的收益。

 

軟體的許可證可以按固定期限訂閱購買或根據使用情況購買。許可證的營業收入在軟體可供客戶使用的時點確認,前提是滿足所有其他營業收入確認標準,並在我們的運營報表中分類爲營業收入。我們的翻譯或翻譯服務費用通常按每分鐘或每字收取,通常採用「按發票計」的簡便方法進行覈算。

 

我們的 服務主要由與培訓和教育相關的費用組成,這些費用是針對某些在特定時間被認可的許可證。 培訓和教育收入在服務執行時確認。

 

8

 

 

收入的分類

 

公司將營業收入分爲訂閱和許可收入以及培訓和教育收入。

 

   截至2024年9月30日的三個月   截至2023年9月30日的三個月   截至2024年9月的九個月   截至2023年9月30日的九個月 
訂閱和許可營業收入  $-   $3,387   $10,876   $44,674 
培訓和教育   3,478    5,775    3,478    12,450 
總營業收入  $3,478   $9,162   $14,354   $57,124 

 

遞延 營業收入

 

遞延 營業收入包括服務和壓力位合同,代表通常爲期一年或更短的協議中的未履行績效義務。截至2024年9月30日和2023年,遞延營業收入爲$16,000 和 $0,分別爲。

 

基本和稀釋後每股虧損

 

基本每股普通股虧損是通過將可供普通股股東的淨虧損除以在此期間的普通股加權平均流通股數來計算的。稀釋每股普通股虧損是根據在此期間的普通股加權平均流通股數來確定的,同時考慮普通股等價物的稀釋效應。在報告虧損的期間,普通股等價物不包括在加權平均流通股數中,因爲它們的包含會導致抗稀釋效應。因此,普通股加權平均流通股數量以及每股的淨虧損金額在2024年和2023年截止9月30日的九個月基本和稀釋每股計算中呈現,在隨附的運營報表中反映。

 

最近的 會計公告

 

公司認爲,任何最近發佈的有效聲明,或者已發佈但尚未生效的聲明,如果被採用, 都不會對附帶的基本報表產生重大影響。

 

注意 3. 重新審計先前發佈的未經審計的中期基本報表

 

在準備其2024財年的基本報表並審查證券交易委員會關於其截至2023年12月31日的10-K表格年度報告的評論過程中,公司在其未經審計的基本報表中發現了錯誤,這些報表涉及截至2024年6月30日和2024年9月30日的期間(「中期」或「受影響期間」)。這些錯誤涉及一般和行政費用的虛報以及額外的實收資本,總額爲$576,160在截至2023年6月30日的六個月和截至2023年9月30日的九個月期間,原因是公司使用了最近一次發行的股票價格,而不是市場價格。

 

公司根據SEC工作人員會計公告("SAB")第99號《重要性》,按照ASC 250("ASC 250")的《基本報表》對這些誤報在以前期間的重要性進行了評估,並認爲這些誤報對任何以前的年度或中期期間都不具有重要性。因此,根據ASC 250(SAB第108號,在量化當前年度基本報表中的誤報時考慮以前年度誤報的影響)。

 

以下提供了受影響期間前報告金額與調整後基本報表中的金額的對賬,適用於截至2023年6月30日和2023年9月30日的資產負債表。標記爲「重述調整」的金額代表重述調整的影響。

 

截至2023年6月30日和2023年9月30日的重述調整說明可以在公司於2024年12月13日提交的2023年9月30日止九個月的修訂版10-Q表中找到。

 

   按報告   調整   經重述 
資產負債表
(未經審計)
  截至2023年6月30日 
   按報告   調整   經重述 
             
額外實收資本  $26,137,940   $(576,160)  $25,561,780 
累計虧損  $(31,798,754)  $576,160   $(31,222,594)

 

9

 

 

   按報告   調整   經重述 
     
資產負債表
(未經審計)
  截至2023年9月30日,
2023
 
   按報告   調整   經重述 
                
額外實收資本  $32,469,830   $(576,160)  $31,893,670 
累計虧損  $(32,856,462)  $576,160   $(32,280,302)

 

   按報告   調整   經重述 
運營報表
(未經審計)
  截至6月30日的六個月內,
2023
 
   按報告   調整   經重述 
             
一般管理費用  $3,516,306   $(576,160)  $2,940,146 
總營業費用   4,064,511    (576,160)   3,488,351 
運營損失   (4,016,549)   576,160    (3,440,389)
淨損失   (4,037,021)   576,160    (3,460,861)
每股虧損 - 基本和攤薄  $(0.15)  $0.02   $(0.13)

 

   按報告   調整   經重述 
運營報表
(未經審計)
  截至9月30日的九個月期間,
2023
 
   按報告   調整   經重述 
             
一般管理費用  $4,031,452   $(576,160)  $3,455,292 
總營業費用   5,120,391    (576,160)   4,544,231 
運營損失   (5,063,267)   576,160    (4,487,107)
淨損失   (5,094,729)   576,160    (4,518,569)
每股虧損 - 基本和攤薄   (0.18)   0.02    (0.16)

 

   按報告   調整   經重述 
現金流量表
(未經審計)
  截至6月30日的六個月內,
2023
 
   按報告   調整   經重述 
             
經營活動產生的現金流量:               
淨損失  $(4,037,021)  $576,160   $(3,460,861)
爲前一年軟體收購而發行的額外股份   2,794,882    (576,160)   2,218,722 
淨現金流出活動  $(960,625)  $   $(960,625)

 

   按報告   調整   經重述 
現金流量表
(未經審計)
  截至9月30日的九個月期間,
2023
 
   按報告   調整   經重述 
             
經營活動產生的現金流量:               
淨損失  $(5,094,729)  $576,160   $(4,518,569)
爲前一年軟體收購而發行的額外股份   2,794,882    (576,160)   2,218,722 
淨現金流出活動  $(1,545,458)  $   $(1,545,458)

 

請注意 4. 持續經營

 

這些 基本報表是根據適用於持續經營的公認會計原則編制的,假設公司能夠履行其義務並在下一個財政年度繼續運營。實現價值 可能與所示的賬面價值有很大不同,這些基本報表沒有考慮如果公司無法繼續作爲持續經營單位所需的賬面價值的調整和資產負債的分類。截止2024年9月30日,公司尚未實現盈利運營,並預計在其業務發展中將繼續虧損,這些都對公司持續經營的能力產生了重大疑問。公司持續經營的能力取決於其產生未來盈利運營和/或獲得必要融資以履行其義務並在到期時償還正常業務運營產生的負債的能力。管理層尚未制定正式計劃來解決這一擔憂,但認爲公司能夠通過股權融資和/或相關方貸款獲得額外資金,但無法保證會有額外資金可用。

 

Note 5. Related Party Transactions

 

Advances, related party

 

During the nine months ended September 30, 2024, Mr. Day advanced the Company $72,000 and was repaid $72,000. The advances are unsecured, non-interest bearing and are payable on demand. As of September 30, 2024, the advances, related party balance owed to Mr. Day were $0.

 

10

 

 

Expense paid on the Company’s behalf

 

During the nine months ended September 30, 2024 and 2023, Mr. Day paid $249,113 and $352,952 of expenses on the Company’s behalf and was repaid $213,042 and $262,850, respectively. As of September 30, 2024 and December 31, 2023, the balance owed to Mr. Day was $40,408 and $4,337, respectively.

 

During the nine months ended September 30, 2024, Mr. Leal paid $8,862 of expenses on the Company’s behalf. As of September 30, 2024, the balance owed to Mr. Leal was $8,862.

 

Founder note

 

Rowland Day, the Company’s prior CEO agreed to provide the necessary working capital for the Company’s business. At the end of each calendar quarter the convertible promissory note is adjusted based upon the funds provided. The convertible promissory note bears interest at 5% and was originally convertible into Series B-1 preferred stock at the rate of $0.10 per share. On October 1, 2023, with no consideration given, Mr. Day agreed to waive the convertible feature on the note payable, related party. During the nine months ended September 30, 2024 and 2023, this Company recorded imputed interest expense of $4,995.

 

As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $221,990, with accrued interest of $41,623 and $33,299, respectively.

 

Senior secured notes payable

 

On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

11

 

 

On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024. The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

12

 

 

On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $549,000 and $0, with accrued interest of $37,904 and $0, respectively.

 

Accrued salary and interest

 

On October 1, 2023, the Company and Mr. Day entered into a settlement and general release agreement. Per the agreement, Mr. Day agreed to settle all accrued salary and interest for service provided prior to September 1, 2022. As a result, the Company recorded a settlement of $351,459 as a contribution to capital during the year ended December 31, 2023. During the nine months ended September 30, 2024, the Company recorded an additional $4,448 as a contribution to capital related to the settlement.

 

Note 6. Equity

 

The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

 

On May 1, 2023, the Articles of Incorporation of the Company were amended to increase the authorized B-1 preferred shares to 8,619,420 shares.

 

Common Stock

 

On February 6, 2024, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000.

 

During the quarter ended June 30, 2024, the Company issued 582,000 shares of common stock at $0.80 per share and collected $465,600.

 

13

 

 

During the quarter ended September 30, 2024, the Company issued 300,000 shares of common stock at $0.75 per share and collected $225,000.

 

Preferred Stock

 

Series A Convertible Preferred Stock

 

In April 2008, our board of directors designated 5,000,000 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended to decrease the authorized Series A shares to 2,068 shares of Series A. Series A has liquidation and dividend preferences. Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. Each share of Series A is convertible on a 1 to 1.25 common share basis. As of each of September 30, 2024 and December 31, 2023, there were 2,068 shares of Series A issued and outstanding.

 

Series B-1 Convertible Preferred Stock

 

In October 2015, our board of directors designated 3,107,438 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with the redemption value of $0.70798 per share. Series B-1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible. Each share of Series B-1 is convertible on a 1 to 11 common share basis. The Company’s Articles of Incorporation require 51% of the outstanding votes of the Series B-1 to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. Series B-1 was included in mezzanine equity on the balance sheet, because it was convertible at the redemption value into a variable number of shares. On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of 2,946,074 shares of Series B-1 Convertible preferred stock to the sole shareholder of Metalanguage who is also the CEO of the Company, Saul Leal. The Board approved the transaction to better align incentives in connection with our Acquisition of MetaLanguage given Mr. Leal’s importance to the Company in continuing to lead and expand the business acquired from him. On September 30, 2023, the Articles of Incorporation of the Company were amended to remove the redemption right of the Series B-1, which was subsequently reclassified from mezzanine equity to permanent equity on the balance sheet. As of September 30, 2024 and December 31, 2023, there are 8,619,420 shares of Series B-1 issued and outstanding.

 

Series B-2 Convertible Preferred Stock

 

In October 2015, our board of directors designated 3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended such that no Series B-2 shares are authorized. Series B-2 have no liquidation or dividend preferences. Each share of Series B-2 has voting rights equal to the amount of shares of common stock the Series A is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of September 30, 2024 and December 31, 2023, there are no shares of Series B-2 issued and outstanding.

 

Stock Warrants

 

The following table summarizes the stock warrant activity for the nine months ended September 30, 2024:

 

   Warrants  

Weighted-Average

Exercise

Price Per Share

 
Outstanding, December 31, 2023   350,000   $1.29 
Granted        
Exercised        
Forfeited        
Expired        
Outstanding, September 30, 2024   350,000   $1.29 

 

14

 

 

As of September 30, 2024 the outstanding and exercisable warrants have a weighted average remaining term of 3.56 with no intrinsic value, respectively.

 

Stock Options

 

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual installments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

 

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i )50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $39,546.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 years, Volatility 120.76% and Discount rate 3.62%.

 

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested. The total fair value of these option grants at issuance was $52,021.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

 

During the nine months ended September 30, 2024, the Company recognized $271,924 of expense related to outstanding stock options.

 

The following table summarizes the stock option activity for the nine months ended September 30, 2024:

 

   Options  

Weighted-Average

Exercise

Price Per Share

 
Outstanding, December 31, 2023   3,645,000   $0.43 
Granted   970,000    0.52 
Exercised        
Forfeited        
Expired        
Outstanding, September 30, 2024   4,615,000   $0.43 
Exercisable, September 30, 2024   580,000   $0.46 

 

As of September 30, 2024, the outstanding and exercisable options have a weighted average remaining term of 4.96 with an intrinsic value of $47,450.

 

15

 

 

Note 7: Commitments

 

On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers.

 

One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

 

Note 8: Subsequent Events

 

On October 8, 2024, the Company entered into an OEM Agreement (the “Agreement”) with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel, whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. NICE is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language translation solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. The Agreement has an exclusivity period of eighteen months and an initial term of three years. Subsequent to September 30, 2024, the Company received $700,000 related to this agreement.

 

On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On October 29, 2024, the Company agreed to issue 1,200,000 options to an employee. The options have a five-year term at an exercise price of $0.75 and vest in 4 equal annual installments beginning one year from the issuance date. The options vest as follows: (i) 600,000 options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning June 30, 2024, and ending on March 31, 2028, until the 600,000 Options are 100% vested. In full satisfaction of the relevant obligation of the Company under the Participant’s employment agreement with the Company, the remaining 600,000 Options will become vested and exercisable as follows until the Option is 100% vested (ii) for a period of four years beginning April 1, 2024, ending March 31 of 2025; April 1, 2025, ending March 31, 2026; April 1, 2026 ending March 31, 2027; and April 1, 2027 ending March 31, 2028, 150,000 Options will vest (subject to meeting certain total new bookings) on March 31 of each year, beginning March 31, 2025. Vesting for each 12-month term is contingent upon Participant exceeding a minimum amount of total new bookings as determined by the Company’s board of directors or their designee. For the 2 first term ending on March 31, 2025. Participant must exceed $5 million of total new bookings for the first vesting of 150,000 options.

 

16

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion of our financial condition and results of operations in conjunction with the condensed financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and with our audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”). In addition to historical condensed financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

 

Overview

 

The Company operates to develop artificial intelligence products that enable companies and individuals to reach their highest potential by eliminating language barriers in daily communications by providing high-quality, accurate, and efficient interpretation and translation services using natural language processing (NLP) technology. The Company’s focus is on developing a proprietary architecture that is faster and more accurate than any other company, with a commitment to providing superior quality services to its customers. The Company intends to serve a wide variety of markets and customers and will be focused on becoming a leader in the creation of pragmatic products for the interpretation and translation industry.

 

Business Summary

 

At the time of its initial formation in 2006, the Company was a development stage company that offered live promotions and marketing events using custom-built mobile displays.

 

Today, the Company is developing a stack of cutting-edge artificial intelligence technologies that solve everyday problems with an innovative and pragmatic approach. Using natural language processing sentiment analytics and behavioral prediction to metaverse enhancement, the Company is attempting to solve problems that will elevate our human condition.

 

The Company has recently launched two products: Verbum, which is a platform that enables fluent and effective communication among individuals that do not speak the same language; and Verbum SDK. Verbum SDK is a software development kit that allows developers to create multi-language translation tools for their own use.

 

Our Products

 

The Company’s current products described in detail below have proprietary technology and associated patents. The Company is currently working on patents for future product offerings.

 

  Verbum. Verbum supports real time web-based conversations, discussions, meetings, and online chats in 150 languages, enabling fluent and effective communication among individuals that do not speak the same language. This product is distributed through our online platform, direct sales to businesses and organizations, and we are attempting to develop partnerships with existing video conferencing providers. The competitive position is against other video conferencing providers that also offer live interpretation services, such as Microsoft Teams, Zoom and Google Meet. We believe our main competitors are organizations that supply human interpreters which can be ten times more expensive than our Verbum product. The primary market for our Verbum product is for organizations or individuals that require real-time interpretation services.
     
  Verbum SDK. Verbum Software Developer Kit allows software programmers, potential channel partners, and corporate development teams to integrate our powerful multilingual communications platform Verbum™ — into new or existing Software-as-a-Service applications and/or client/server programs, helping them remove communications barriers for multinational organizations and/or those serving customers who speak/read different languages. This product may be distributed through partnerships with software developers or through direct sales to businesses and organizations that require interpretation services for their software. The competitive position would be against other software development kit providers that also offer interpretation services, such as Microsoft Azure or Amazon Translate. The expected market for this product is software developers and businesses that require interpretation services for their software applications.

 

17

 

 

 

Components of Our Results of Operations

 

Net Revenue

 

We currently derive our revenue primarily from the sale of our products. We expect our net revenue to increase in the foreseeable future as we add new customers and offer additional products, though net revenue may fluctuate from quarter to quarter due to a variety of factors, including the pace of research and development and completion of additional products.

 

Operating Expenses

 

Operating expenses consist primarily of research and development, salaries and benefits, infrastructure and equipment, professional services and distribution and delivery.

 

Research and Development: Developing and maintaining the proprietary NLP technology and architecture will be a significant future expense for the Company. This will include expenses related to hiring and retaining top talent, conducting research and development, and investing in technology infrastructure and equipment.

 

Salaries and Benefits: The Company plans to invest in hiring and retaining additional employees to perform various functions, such as software development, customer support, sales, and administration. This will include salaries, benefits, and other employee-related expenses.

 

Infrastructure and Equipment: The Company will invest in technology infrastructure and equipment to support its software development and distribution operations. This will include expenses related to servers, software licenses, hardware, and office equipment.

 

Professional Services: Depending on the Company’s needs, it may need to engage professional services such as legal, accounting, or consulting services, which would be an expense for the Company.

 

Distribution and Delivery: The Company will need to invest in distribution and delivery methods for its products, such as software updates, shipping, or online delivery. This will include expenses related to logistics, software licensing, or server maintenance.

 

Total Other Expense

 

Other expenses consist primarily of interest expense. It also includes any gains and loss attributable to the changes in fair market value from the derivative liabilities associated with the issuance of convertible notes.

 

18

 

 

Results of Operations for the Three Months Ended September 30, 2024 and 2023

 

The following table summarizes selected items from the statement of operations for the three months ended September 30, 2024 and 2023, respectively.

 

   Three months
ended
   Three months
ended
  


 
  

September 30,

2024

  

September 30,

2023

  

Increase/

(Decrease)

 
             
Revenue  $3,478   $9,162   $(5,684)
Total revenue   3,478    9,162    (5,684)
                
Operating expenses:               
Research and development   202,168    203,588    (1,420)
General and administrative   537,164    515,146    22,018 
Advertising and marketing   25,336    71,253    (45,917)
Legal and professional   139,600    265,893    (126,293)
                
Total operating expenses   904,268    1,055,880    (151,612)
                
Loss from operations   (900,790)   (1,046,718)   (145,928)
                
Other expense:               
                
Interest expense   (34,563)   (10,990)   23,573 
                
Total other expense   (34,563)   (10,990)   23,573 
                
Net loss  $(935,353)  $(1,057,708)  $(122,355)

 

Net Revenue

 

Our net revenue for the three months ended September 30, 2024 was $3,478, compared to $9,162 for the three months ended September 30, 2023, a decrease of $5,684. We had little revenue for both periods as our products have been in the development stage and we have not secured any large-scale customer contracts.

 

Operating Expenses

 

Our total operating expenses for the three months ended September 30, 2024, were $904,268, compared to $1,055,880 for the three months ended September 30, 2023, a decrease of $151,612. The decrease in our operating expenses was primarily a result of: (i) a decrease in advertising and marketing expenses, from $71,253 for the three months ended September 30, 2023 to $25,336 for the three months ended September 30, 2024; and (ii) a decrease in legal and professional expenses, from $265,893 for the three months ended September 30, 2023 to $139,600 for the three months ended September 30, 2024.

 

Other Expense

 

For the three months ended September 30, 2024, other expense was $34,563. For the three months ended September 30, 2023, other expense was $10,990. Other expense increased by $23,573 primarily due to an increase in interest expense for senior secured notes in 2024.

 

19

 

 

Net Loss

 

Net loss for the three months ended September 30, 2024, was $935,353, compared to $1,057,708 for the three months ended September 30, 2023, a decreased net loss of $122,355. The decreased net loss was primarily due to a $145,928 decrease in operating expenses.

 

Results of Operations for the Nine Months Ended September 30, 2024 and 2023

 

The following table summarizes selected items from the statement of operations for the nine months ended September 30, 2024 and September 30, 2023, respectively.

 

   Nine months
 ended
   Nine months
 ended
     
  

September 30,

2024

  

September 30,

2023

   Increase/
(Decrease)
 
             
Revenue  $14,354   $57,124   $(42,770)
Total revenue   14,354    57,124    (42,770)
                
Operating expenses:               
Research and development   653,732    540,092    113,640 
General and administrative   1,672,388    3,455,292    (1,782,904)
Advertising and marketing   78,809    161,038    (82,229)
Legal and professional   491,733    387,809    103,924 
                
Total operating expenses   2,896,662    4,544,231    (1,647,569)
                
Loss from operations   (2,882,308)   (4,487,107)   1,604,799
                
Other expense:               
                
Interest expense   (60,655)   (31,462)   29,193 
                
Total other expense   (60,655)   (31,462)   29,193 
                
Net loss  $(2,942,963)  $(4,518,569)  $1,575,606

 

Net Revenue

 

Our net revenue for the nine months ended September 30, 2024 was $14,354, compared to $57,124 for the nine months ended September 30, 2023, a decrease of $42,770. We had little revenue for both periods as our products have been in the development stage and we have not secured any large-scale customer contracts.

 

20

 

 

Operating Expenses

 

Our total operating expenses for the nine months ended September 30, 2024, was $2,896,662, compared to $4,544,231 for nine months ended September 30, 2023, a decrease of $1,647,569. The decrease in our operating expenses was primarily a result of a decrease in (i) general and administrative expenses, from $3,455,292 for nine months ended September 30, 2023 to $1,672,388 for nine months ended September 30, 2024, and (ii) advertising and marketing expenses, from $161,038 for nine months ended September 30, 2023 to $78,809 for nine months ended September 30, 2024.

 

Other Expense

 

In the nine months ended September 30, 2024, other expense was $60,655. For the nine months ended September 30, 2023, other expense was $31,462. Other expense increased by $29,193 primarily due to an increase in interest expense for senior secured notes in 2024.

 

Net loss

 

Net loss for the nine months ended September 30, 2024 was $2,942,963, compared to $4,518,569 for the nine months ended September 30, 2023, a decrease of $1,575,606. The decrease in net loss was primarily due to a $1,647,569 decrease in operating expenses.

 

Liquidity and Capital Resources

 

The following table summarizes our total current assets, liabilities and working capital as of September 30, 2024 and December 31, 2023.

 

   September 30,   December 31, 
   2024   2023 
Current Assets  $46,606   $1,143,690 
           
Current Liabilities  $1,864,831   $1,025,919 
           
Working Capital (Deficit)  $(1,818,225)  $117,771 

 

As of September 30, 2024, we had a working capital deficit of $1,818,225. We have incurred net losses since our inception and we anticipate net losses and negative operating cash flows for the near future and we may not be profitable or realize growth in the value of our assets. To date, our primary sources of capital have been cash generated from common stock sales and debt financing. As of September 30, 2024, we had cash of $24,254, total liabilities of $1,864,831, and an accumulated deficit of $36,851,759. As of December 31, 2023, we had cash of $1,129,935, total liabilities of $1,025,919, and an accumulated deficit of $33,908,796.

 

Cash Flow

 

Comparison of the Nine Months Ended September 30, 2024 and the Nine Months Ended September 30, 2023

 

The following table sets forth the primary sources and uses of cash for the periods presented below:

 

   Nine Months Ended 
   September 30, 
   2024   2023 
Net cash used in operating activities  $(2,380,281)  $(1,545,458)
Net cash provided by financing activities   1,274,660    1,358,000 
           
Net change in cash  $(1,105,681)  $(187,458)

 

21

 

 

Net Cash Used in Operating Activities

 

Net cash used in operating activities was $2,380,281 for the nine months ended September 30, 2024, compared to $1,545,458 for the nine months ended September 30, 2023, an increase of $834,823. The change was primarily attributable to increases in non-cash expenses related to stock-based compensation , accrued expenses and deferred revenue.

 

Net Cash Provided by Financing Activities

 

Net cash provided by financing activities was $1,274,660 for the nine months ended September 30, 2024, compared to $1,358,000 for the nine months ended September 30, 2023, a decrease of $83,340. The decrease in cash provided by financing activities was primarily attributable to our decrease in sales of our common stock which were offset by increases in proceeds from senior secured notes payable, related party.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our financial results are affected by the selection and application of accounting policies and methods. In the nine-month period ended September 30, 2024, there were no changes to the application of critical accounting policies previously disclosed in the 2023 Form 10-K.

 

CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS

 

This report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are “forward-looking statements” for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of our management for future operations, any statements concerning proposed new products or services, any statements regarding the integration, development or commercialization of the business or any assets acquired from other parties, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “potential,” “forecasts,” “continue,” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results will likely differ, and could differ materially, from those projected or assumed in the forward-looking statements. Investors are cautioned not to unduly rely on any such forward-looking statements.

 

All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Our actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. If we do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections.

 

NOTICE REGARDING TRADEMARKS

 

This report includes trademarks, tradenames and service marks that are our property or the property of others. Solely for convenience, such trademarks and tradenames sometimes appear without any “™” or “®” symbol. However, failure to include such symbols is not intended to suggest, in any way, that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.

 

22

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management is responsible for establishing and maintaining adequate disclosure controls and procedures for our company. Consequently, our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act as of September 30, 2024. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

During the nine-month period ended September 30, 2024, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934).

 

23

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not currently party to any pending legal proceedings that we believe would, individually or in the aggregate, have a material adverse effect on our financial condition, cash flows or results of operations.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide information typically disclosed under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Common Stock

 

On February 6, 2024, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000.

 

During the three months ended June 30, 2024, the Company issued 582,000 shares of common stock at $0.80 per share and collected $465,600.

 

During the three months ended September 30, 2024, the Company issued 300,000 shares of common stock at $0.75 per share and collected $225,000.

 

Stock Warrants

 

As of September 30, 2024 the outstanding and exercisable warrants have a weighted average remaining term of 3.56 with no intrinsic value, respectively.

 

Stock Options

 

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual installments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

 

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i )50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $39,546.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 years, Volatility 120.76% and Discount rate 3.62%.

 

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested. The total fair value of these option grants at issuance was $52,021.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

 

During the nine months ended September 30, 2024, the Company recognized $271,924 of expense related to outstanding stock options.

 

As of September 30, 2024, the outstanding and exercisable options have a weighted average remaining term of 4.96 with an intrinsic value of $47,450.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

The disclosure required by this item is not applicable.

 

ITEM 5. OTHER INFORMATION

 

During the nine months ended September 30, 2024, no director or officer adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.

 

24

 

 

ITEM 6. EXHIBITS.

 

Exhibit   Description
3.1**   Amended and Restated Articles of Incorporation.
3.2**   Amended and Restated Bylaws.
3.4**   ONEMETA AI – NV – Secretary of State – Amendment Filing
3.5**   Amendment to Certificate of Designation Series B
3.6**   Certificate of Designation Final – Series A-1
3.7**   Certificate of Designation Series B-1 and Related Certificates of Change
21.1**   Subsidiaries of OneMeta Inc.
31.1*   Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
31.2*   Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
32.1*   Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

* Filed herewith
** Previously filed
Indicates management contract or compensatory plan or arrangement

 

25

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registration has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Signature   Title   Date
         
/s/ Saul Leal   Chief Executive Officer   December 13, 2024
Saul Leal   (Principal Executive Officer)    
         
/s/ Rowland Day   President, Chief Financial Officer   December 13, 2024
Rowland Day   (Principal Accounting and Financial Officer)    

 

26